News from bacterin international holdings, inc

Nov 07, 2012, 16:00 ET

Bacterin Reports Third Quarter 2012 Financial Results

 Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Oct 23, 2012, 12:05 ET

Bacterin to Present at 7th Annual Singular Research Conference

 Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Sep 12, 2012, 09:53 ET

John Deedrick Joins Bacterin Board of Directors

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings...

Sep 11, 2012, 09:00 ET

Positive Clinical Results on the use of Bacterin's OsteoSponge® SC Product for Regeneration of Subchondral Bone Published in Foot & Ankle Specialist

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings...

Aug 31, 2012, 09:00 ET

Bacterin International to Present at Stifel Nicolaus 2012 Healthcare Conference on September 6, 2012

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Aug 28, 2012, 08:30 ET

Bacterin Secures $25 Million Financing with OrbiMed

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of unique bone graft material and antimicrobial coatings for...

Aug 09, 2012, 16:00 ET

Bacterin International Announces Second Quarter and Six Months 2012 Financial Results

 Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Jul 27, 2012, 09:00 ET

Bacterin International Holdings, Inc. Schedules Second Quarter 2012 Financial Earnings Conference Call

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and...

Jul 10, 2012, 08:44 ET

Bacterin International Signs Its Fourth National GPO Contract with the Premier healthcare alliance

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Jul 03, 2012, 16:00 ET

Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders

Bacterin International Holdings, Inc. (NYSE MKT LLC: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

May 30, 2012, 16:00 ET

Bacterin to Present at the Jefferies 2012 Global Healthcare Conference

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

May 08, 2012, 08:30 ET

Bacterin International Signs Its Third National GPO Contract with Novation

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

May 03, 2012, 16:00 ET

Bacterin Announces First Quarter 2012 Revenue of $7.8 Million, Up 29% Year-over-Year, on Gross Margins of 76%, and 34% Reduction in Operating Loss

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Apr 24, 2012, 16:22 ET

Bacterin International Holdings, Inc. Schedules First Quarter 2012 Financial Earnings Conference Call

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Apr 24, 2012, 07:00 ET

Bacterin Secures Accounts Receivable Credit Facility

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Apr 04, 2012, 07:00 ET

Peer Review Determines Bacterin's OsteoSponge® Superior to Autograft and Ideal for Bone Regeneration in Dove Press Journal

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Mar 12, 2012, 16:00 ET

Bacterin to Present at the 5th Annual Maxim Group Growth Conference on March 26, 2012

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Feb 10, 2012, 17:54 ET

Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge® Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and...

Feb 07, 2012, 09:00 ET

Bacterin Promotes Seasoned Healthcare Sales Professional to National Sales Manager

 Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Feb 01, 2012, 16:10 ET

Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program

Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer